Calcium-activated pathways and oxidative burst mediate zymosan-induced signaling and IL-10 production in human macrophages.
Outside of the TLR paradigm, there is little understanding of how pathogen recognition at the cell surface is linked to functional responses in cells of the innate immune system. Recent work in this area demonstrates that the yeast particle zymosan, by binding to the beta-glucan receptor Dectin-1, activates an ITAM-Syk-dependent pathway in dendritic cells, which is required for optimal cytokine production and generation of an oxidative burst. It remains unclear how activation of Syk is coupled to effector mechanisms. In human macrophages, zymosan rapidly activated a calcium-dependent pathway downstream of Dectin-1 and Syk that led to activation of calmodulin-dependent kinase II and Pyk2. Calmodulin-dependent kinase and Pyk2 transduced calcium signals into activation of the ERK-MAPK pathway, CREB, and generation of an oxidative burst, leading to downstream production of IL-10. These observations identify a new calcium-mediated signaling pathway activated by zymosan and link this pathway to both inflammatory and anti-inflammatory responses in macrophages.
Kelly
Erin K
EK
Graduate Program in Cell Biology and Genetics, Weill Cornell Graduate School of Medical Sciences, New York, NY 10021, USA.
Wang
Lu
L
Ivashkiv
Lionel B
LB
D020013:Calcium Signaling / Q000187:drug effects / Q000276:immunology*; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000378:metabolism / Q000502:physiology; D002147:Calmodulin / Q000037:antagonists & inhibitors; D002478:Cells, Cultured; D017362:Cyclic AMP Response Element-Binding Protein / Q000097:blood; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004533:Egtazic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D016753:Interleukin-10 / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000097:blood; D020935:MAP Kinase Signaling System / Q000187:drug effects / Q000276:immunology; D008264:Macrophages / Q000276:immunology* / Q000378:metabolism* / Q000473:pathology; D016897:Respiratory Burst / Q000187:drug effects / Q000276:immunology*; D013449:Sulfonamides / Q000494:pharmacology; D051746:ZAP-70 Protein-Tyrosine Kinase / Q000378:metabolism; D015054:Zymosan / Q000037:antagonists & inhibitors / Q000494:pharmacology*
C115163:CREB1 protein, human; D002147:Calmodulin; D017362:Cyclic AMP Response Element-Binding Protein; C508609:IL10 protein, human; D013449:Sulfonamides; D016753:Interleukin-10; D004533:Egtazic Acid; C017967:W 7; D015054:Zymosan; D051746:ZAP-70 Protein-Tyrosine Kinase; C497261:ZAP70 protein, human; D017871:Calcium-Calmodulin-Dependent Protein Kinases; C025603:1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; D004121:Dimethyl Sulfoxide
Nat Rev Immunol. 2004 May;4(5):348-59
15122200
Blood. 2005 Oct 1;106(7):2543-50
15956283
Nature. 1996 Oct 10;383(6600):547-50
8849729
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13766-71
11095740
Nat Immunol. 2009 Feb;10(2):203-13
19122653
Nat Immunol. 2007 Jan;8(1):31-8
17159984
J Exp Med. 2002 Aug 5;196(3):407-12
12163569
Free Radic Biol Med. 2007 Jan 15;42(2):153-64
17189821
Nat Immunol. 2007 Jun;8(6):630-8
17450144
Nat Immunol. 2006 Dec;7(12):1258-65
17110942
Nat Immunol. 2008 Feb;9(2):186-93
18084294
J Exp Med. 2003 May 5;197(9):1107-17
12719479
J Biol Chem. 2007 Apr 27;282(17):12397-409
17339324
Eur J Immunol. 2008 Feb;38(2):500-6
18200499
Blood. 2007 Mar 15;109(6):2461-9
17095622
J Exp Med. 2003 Jan 6;197(1):63-75
12515814
Immunity. 2005 Apr;22(4):507-17
15845454
Nat Immunol. 2007 Jan;8(1):39-46
17159982
J Clin Invest. 2006 Apr;116(4):916-28
16543948
Eur J Immunol. 2007 Feb;37(2):467-78
17230442
Science. 1958 Apr 4;127(3301):756-7
13543326
Nat Immunol. 2007 Jun;8(6):619-29
17486093
Eur J Immunol. 2007 Jun;37(6):1600-12
17458858
J Biol Chem. 2006 Jan 20;281(3):1371-80
16291755
J Immunol. 2006 Jul 15;177(2):1282-8
16818788
J Exp Med. 2003 May 5;197(9):1119-24
12719478
J Biol Chem. 2006 Oct 20;281(42):31647-58
16920714
J Immunol. 2006 Jul 1;177(1):459-67
16785543
J Immunol. 2005 Jul 1;175(1):469-77
15972681
Trends Immunol. 2007 Feb;28(2):66-73
17197236
Immunity. 2006 May;24(5):563-74
16713974
Annu Rev Pharmacol Toxicol. 2001;41:471-505
11264466
J Immunol. 2007 Mar 1;178(5):3107-15
17312158
Science. 1991 Jun 7;252(5011):1427-30
1646483
Cell. 2002 Dec 27;111(7):927-30
12507420
J Immunol. 2007 Oct 1;179(7):4598-607
17878357
Nature. 2006 Aug 10;442(7103):651-6
16862125
J Biol Chem. 2009 Mar 13;284(11):7038-46
19136564
Nat Immunol. 2007 Feb;8(2):198-205
17187069
Cell Signal. 2000 Mar;12(3):123-33
10704819
J Immunol. 1997 Nov 15;159(10):5070-8
9366435
Sci STKE. 2007 Mar 13;2007(377):re2
17356173
J Immunol. 1998 Jan 1;160(1):434-43
9552001
Blood. 2004 Dec 15;104(13):4038-45
15304394
Nat Immunol. 2005 Aug;6(8):777-84
16007092
Immunol Res. 2002;26(1-3):95-105
12403349